Oncology division

Quote


































































anonymous said:
Awe, don’t be jealous. I’m sure you will be swooped up by a better company and get a 30k raise soon also.
Click to expand...
Cool so you are finlay at $200K base. Good for you. Oh I no longer work here. I just swing by from time to time for the entertainment. Funny how nothing seems to change. Have fun at GSK...I'm sure you'll fit in nicely.
 












And I am done. 3 years is all I could take. Funny that they cut my access off as soon as I gave notice, hope they don't need anything from me. This place needs an overhaul. When I first started, there were a couple of managers that knew what they were doing but have disappeared. I would love to know where people have gone and how it's worked out. Anything is an upgrade. Oncology doesn't seem to have a future or any direction.
 












anonymous said:
And I am done. 3 years is all I could take. Funny that they cut my access off as soon as I gave notice, hope they don't need anything from me. This place needs an overhaul. When I first started, there were a couple of managers that knew what they were doing but have disappeared. I would love to know where people have gone and how it's worked out. Anything is an upgrade. Oncology doesn't seem to have a future or any direction.
Click to expand...
If you look at the turnover here, it's obvious that everyone is looking to leave. I have been here a long time, I make nightingale every 4 or 5 years and they leave me alone most of the time until I got a new manager a few years back. I'm only going to work another 5 years so Ill keep my head down for now. There are only 2 or 3 managers that so anything and you are right, the good ones left.
 






anonymous said:
And I am done. 3 years is all I could take. Funny that they cut my access off as soon as I gave notice, hope they don't need anything from me. This place needs an overhaul. When I first started, there were a couple of managers that knew what they were doing but have disappeared. I would love to know where people have gone and how it's worked out. Anything is an upgrade. Oncology doesn't seem to have a future or any direction.
Click to expand...
Not going to happen. Unfortunately this has been an issue ever since Eisai entered into oncology with the purchase of MGI and the Ligand Hem division. Eisai has always had a mass market, primary care mentality from a commercial perspective. It's unshakable due to who and where they hire commercial leadership from. If your recruiting ground is NJ Big Pharma, no matter the speciality, your division will feel like big pharma. Where to people go? Well the goal is the start up biotech's in the bay area and Boston. They pay better, the benefits are better, as is the culture, the vibe, and when you add in a strong equity position people buy in and feel like they are apart of something bigger. Eisai is a multinational conglomerate, and it feels as such. Rarely do oncology reps break free from big pharma to a biotech and come back...how many Genetech, Biogen, SeaGen, people do we have here? Next to none.
 






anonymous said:
Not going to happen. Unfortunately this has been an issue ever since Eisai entered into oncology with the purchase of MGI and the Ligand Hem division. Eisai has always had a mass market, primary care mentality from a commercial perspective. It's unshakable due to who and where they hire commercial leadership from. If your recruiting ground is NJ Big Pharma, no matter the speciality, your division will feel like big pharma. Where to people go? Well the goal is the start up biotech's in the bay area and Boston. They pay better, the benefits are better, as is the culture, the vibe, and when you add in a strong equity position people buy in and feel like they are apart of something bigger. Eisai is a multinational conglomerate, and it feels as such. Rarely do oncology reps break free from big pharma to a biotech and come back...how many Genetech, Biogen, SeaGen, people do we have here? Next to none.
Click to expand...
Great point!!
 






anonymous said:
Not going to happen. Unfortunately this has been an issue ever since Eisai entered into oncology with the purchase of MGI and the Ligand Hem division. Eisai has always had a mass market, primary care mentality from a commercial perspective. It's unshakable due to who and where they hire commercial leadership from. If your recruiting ground is NJ Big Pharma, no matter the speciality, your division will feel like big pharma. Where to people go? Well the goal is the start up biotech's in the bay area and Boston. They pay better, the benefits are better, as is the culture, the vibe, and when you add in a strong equity position people buy in and feel like they are apart of something bigger. Eisai is a multinational conglomerate, and it feels as such. Rarely do oncology reps break free from big pharma to a biotech and come back...how many Genetech, Biogen, SeaGen, people do we have here? Next to none.
Click to expand...
The Japs are always trying do things on the cheap. They think that counting pennies makes them great businessmen. It's a cultural thing. They'll never invest what it takes to build a world class business. They're incapable of even conceiving it.
 












Top Bottom
Back
Quote